Research progress of RNA pseudouridine modification in nervous system
Authors:
- 29 February 2024
- journal article
- research article
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 135 (6) , 639-649
Abstract
Recent advances of pseudouridine (Ψ, 5-ribosyluracil) modification highlight its crucial role as a post-transcriptional regulator in gene expression and its impact on various RNA processes. Ψ synthase (PUS), a category of RNA-modifying enzymes, orchestrates the pseudouridylation reaction. It can specifically recognize conserved sequences or structural motifs within substrates, thereby regulating the biological function of various RNA molecules accurately. Our comprehensive review underscored the close association of PUS1, PUS3, PUS7, PUS10, and dyskerin PUS1 with various nervous system disorders, including neurodevelopmental disorders, nervous system tumors, mitochondrial myopathy, lactic acidosis and sideroblastic anaemia (MLASA) syndrome, peripheral nervous system disorders, and type II myotonic dystrophy. In light of these findings, this study elucidated how Ψ strengthened RNA structures and contributed to RNA function, thereby providing valuable insights into the intricate molecular mechanisms underlying nervous system diseases. However, the detailed effects and mechanisms of PUS on neuron remain elusive. This lack of mechanistic understanding poses a substantial obstacle to the development of therapeutic approaches for various neurological disorders based on Ψ modification.Keywords
Funding Information
- Baise City Science and Technology Plan Project Area Multiple Disease Joint Special Plan Project (20224142)
This publication has 80 references indexed in Scilit:
- Decoding the ‘Fifth’ Nucleotide: Impact of RNA Pseudouridylation on Gene Expression and Human DiseaseMolecular Biotechnology, 2023
- Author Correction: Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasionInvestigational New Drugs, 2022
- PUS3‐related disorder: Report of a novel patient and delineation of the phenotypic spectrumAmerican Journal of Medical Genetics Part A, 2021
- Naturally occurring modified ribonucleosidesWIREs RNA, 2020
- Biochemical insight into pseudouridine synthase 7 (PUS7) as a novel interactor of sirtuin, SIRT1Biochemical and Biophysical Research Communications, 2019
- PUS7 mutations impair pseudouridylation in humans and cause intellectual disability and microcephalyHuman Genetics, 2019
- Variants in PUS7 Cause Intellectual Disability with Speech Delay, Microcephaly, Short Stature, and Aggressive BehaviorThe American Journal of Human Genetics, 2018
- Discovery, properties, and biosynthesis of pseudouridimycin, an antibacterial nucleoside-analog inhibitor of bacterial RNA polymeraseJournal of Industrial Microbiology and Biotechnology, 2018
- A homozygous truncating mutation in PUS3 expands the role of tRNA modification in normal cognitionHuman Genetics, 2016
- Mass spectrometry of the fifth nucleoside: A review of the identification of pseudouridine in nucleic acidsAnalytica Chimica Acta, 2008